MRK/CBST: If it happens - I hope it does - that's the real answer to your question on Acute Hospital Care in MSG#167360, and my attempted answer of buy/license back then in MSG#167364.
Pure antibiotics space has seen the busiest acquisition in biotech for the last two years: in addition to the acquisition of public companies like TSRX, OPTR, DRTX, several private companies were acquired as well.
Market Data 
Markets 
AI
